Eli Lilly

Lilly was founded in 1876 by Colonel Eli Lilly, a man committed to creating high-quality medicines that met real needs in an era of unreliable elixirs peddled by questionable characters. His charge to the generations of employees who have followed was this: "Take what you find here and make it better and better." More than 145 years later, we remain committed to his vision through every aspect of our business and the people we serve starting with those who take our medicines, and extending to health care professionals, employees and the communities in which we live. Lilly unites caring with discovery to create medicines that make life better for people around the world. Three long-established core values guide all that we do at Lilly.

• Integrity: We conduct our business consistent with all applicable laws and are honest in our dealings with customers, employees, shareholders, partners, suppliers, competitors and the community
• Excellence: We pursue pharmaceutical innovation, provide high-quality products and strive to deliver superior business results.
• Respect for People: We maintain an environment built on mutual respect, openness and individual integrity. This includes our concern for all people who touch or are touched by our company: customers, employees, shareholders, partners, suppliers and communities.

Discovery is our calling. It is the spirit that has defined us since the day Colonel Eli Lilly opened the doors of our first laboratory in Indianapolis. Over 140 years and nearly 100 medicines later, we keep looking for the next great discovery and for even more ways to make life better for people around the world.
Visit us at the Eli Lilly stand for a coffee chat with one of our representatives.

Novo Nordisk

Novo Nordisk is a leading global healthcare company, founded in 1923. Our purpose is to drive change to defeat diabetes and other serious chronic diseases such as obesity, rare blood and endocrine disorders. We do so by pioneering scientific breakthroughs, expanding access to our medicines and working to prevent and ultimately cure disease. For more visit novonordisk.com

Medtronic

72 million. In the past year, Medtronic therapies improved the lives of 72 million people. That’s two people every second of every hour of every day – and counting. We lead global healthcare technology and boldly attack the most challenging health problems facing humanity by searching out and finding solutions. Our Mission — to alleviate pain, restore health, and extend life — unites a global team of 90,000+ passionate people. Powered by our diverse knowledge, insatiable curiosity, and desire to help all those who need it, we deliver innovative technologies that transform the lives. Powered by our diverse knowledge, insatiable curiosity, and desire to help all those who need it, the Medtronic Diabetes Operating Unit specialises in innovative technologies that can help people with diabetes improve their outcomes, while relieving the burden of disease. Our innovation strategy is aimed primarily at developing artificial pancreas technology, where an insulin pump system is integrated with a continuous glucose monitor to drive automated insulin delivery (advanced hybrid closed loop therapy). We also offer innovative stand-alone continuous glucose monitoring (CGM) and smart MDI solutions, as alternative therapy choices for patients, addressing their individual needs. We are inspired by the patients we serve and are committed to creating access to therapies that give them the freedom to live their lives. Expect more from us as we empower insight-driven care, experiences that put people first, and better outcomes for our world.

In everything we do, we are engineering the extraordinary.
https://hcp.medtronic-diabetes.com/en-GB

Boehringer-Ingelheim

Boehringer Ingelheim is working on breakthrough therapies that transform lives, today and for generations to come. As a leading research-driven biopharmaceutical company, the company creates value through innovation in areas of high unmet medical need. Founded in 1885 and family-owned ever since, Boehringer Ingelheim takes a long-term perspective. More than 52,000 employees serve over 130 markets in the three business areas, Human Pharma, Animal Health, and Biopharmaceutical Contract Manufacturing. Learn more at www.boehringer-ingelheim.com
Boehringer Ingelheim - Value Through Innovation | Boehringer Ingelheim
Boehringer Ingelheim is one of the world's leading research-driven pharmaceutical companies with 130 years of experience.
Boehringer Ingelheim - Value Through Innovation | Boehringer Ingelheim
Boehringer Ingelheim is one of the world's leading research-driven pharmaceutical companies with 130 years of experience

Servier Laboratories

We are an international and independent pharmaceutical company governed by a non-profit foundation, with headquarters in Suresnes, France.

Operating in 149 countries, we have 22,000 collaborators employed worldwide and a turnover of 4.176 billion euros in 2018. Entirely independent, we are able to reinvest 25% of our total revenue (excluding generics) into Research and Development, and all profits are used for further development.

Corporate growth at Servier is driven by our continuous pursuit of innovation in five areas of excellence: cardiovascular and immune-inflammatory diseases, neuropsychiatric disorders, cancer and diabetes. We are a leading force in cardiology—number 2 in Europe, number 5 worldwide—and oncology has become a top priority in recent years; we also manufacture high-quality generic drugs.

Becoming a key player in oncology is part of Servier’s long-term strategy. Currently, there are nine molecular entities in clinical development in this area, targeting gastric and lung cancers and other solid tumors, as well as various leukemias and lymphomas. This portfolio of innovative cancer treatments is being developed with partners worldwide, and covers different cancer hallmarks and modalities, including cytotoxics, proapoptotics, targeted, immune and cellular therapies

Sanofi

In our endeavour to improve the lives of patients, partners and communities, we believe that cutting-edge science and manufacturing, fueled by data and digital technologies, have the potential to transform the practice of medicine. Our mission is to turn the impossible into possible for millions of people around the world. In pursuing the miracles of science to improve people’s lives, we surprise ourselves with what we can achieve. And when we discover the extraordinary, we’re already planning where to go next. Sanofi, chasing the miracles of science to improve people’s lives. https://www.sanofi.co.za

Aspen

With a 160-year heritage, Aspen is a global specialty and branded multinational pharmaceutical company with a presence in both emerging and developed markets. We have approximately 9 800 employees at 71 established offices in over 50 countries and we improve the health of patients in more than 150 countries through our high quality, affordable products. Aspen focuses on manufacturing and marketing a broad range of post-patent, branded medicines, and domestic brands covering both hospital and consumer markets through our key business segments. These key business segments are Manufacturing and Commercial Pharmaceuticals comprising Regional Brands and Sterile Focus Brands that includes Anaesthetics and Thrombosis products.

https://www.aspenpharmasa.co.za/aspen-pharmacare/

AstraZeneca

OUR VISION OF TOMORROW INSPIRES OUR ACTIONS OF TODAY

Science can change our vision of the world and how we deal with the diseases that affect us. The future of treatment for many of today’s diseases lies in uncovering disease mechanisms that are newly emerging or are still to be discovered. Science challenges us to push the limits of what is possible to deliver life-changing medicines for patients in Africa. This is why we put science at the centre of everything we do.

AstraZeneca African Cluster

Merck

Our passion for science and technology is what drives our 58,000 employees in 66 countries to find solutions to some of today’s toughest challenges and create more sustainable ways to live. We are here for people at every step, helping to create, improve and prolong life. We deliver personalized treatments for serious diseases and enable people to achieve their dream of becoming parents. We empower the scientific community. Our tools, services and digital platforms make research simpler, more exact, and help to deliver breakthroughs more quickly. Our solutions accelerate access to health by ensuring tests are accurate and the medicine we take can be trusted. We are the company behind the companies, advancing digital living. Our science sits inside technologies that are changing the way we access, store, process, and display information. Our innovations are unlocking the power and potential of data to open new possibilities to transform life on Earth as we know it. We believe that scientific exploration and responsible entrepreneurship are key to technological advances that benefit us all. This is how Merck has thrived since 1668. And we will continue to push the boundaries of possibility to create opportunities for everyone. This is what drives us. This is what we work for. This is our future. www.merck.co.za